Technology
Health
Medical

Nymox Pharmaceuticals

$1.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.62%) As of 12:41 PM EDT today
+$0.01 (0.62%) Today

Why Robinhood?

You can buy or sell NYMX and other stocks, options, ETFs, and crypto commission-free!

About NYMX

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. Read More It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.

Employees
5
Headquarters
Nassau, New Providence
Founded
1995
Market Cap
110.04M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
110.49K
High Today
$1.72
Low Today
$1.60
Open Price
$1.60
Volume
75.47K
52 Week High
$3.35
52 Week Low
$1.25

Collections

Technology
Health
Medical
North America (Non-US/Canada)
North America
US

NYMX Earnings

-$0.06
-$0.05
-$0.05
-$0.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 13
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.